Potential Drug Combinations to Reduce Cardiovascular Disease Burden in Diabetes

Lowering plasma TG or increasing high-density lipoprotein (HDL) do not seem to offer benefits above the standard of care in diabetics. Therapeutic targets that prevent glucose and lipid absorption appear to be promising in reducing CVD burden in patients with diabetes. Emerging data suggest that mechanisms that promote glucose removal through the kidney appear to show cardiovascular and mortality benefits in patients with diabetes. Reducing...